Related references
Note: Only part of the references are listed.Convergence of Prognostic Gene Signatures Suggests Underlying Mechanisms of Human Prostate Cancer Progression
Bogdan-Alexandru Luca et al.
GENES (2020)
Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of chemoradiotherapy failure independent of intratumour heterogeneity
Christina S. Fjeldbo et al.
EBIOMEDICINE (2020)
Multifocal Primary Prostate Cancer Exhibits High Degree of Genomic Heterogeneity
Marthe Lovf et al.
EUROPEAN UROLOGY (2019)
PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway
Anwar R. Padhani et al.
RADIOLOGY (2019)
Interfocal heterogeneity challenges the clinical usefulness of molecular classification of primary prostate cancer
Kristina Totland Carm et al.
SCIENTIFIC REPORTS (2019)
Biomarkers Associated with Tumor Heterogeneity in Prostate Cancer
Jae Won Yun et al.
TRANSLATIONAL ONCOLOGY (2019)
Combined MR Imaging of Oxygen Consumption and Supply Reveals Tumor Hypoxia and Aggressiveness in Prostate Cancer Patients
Tord Hompland et al.
CANCER RESEARCH (2018)
Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity
Emelie Berglund et al.
NATURE COMMUNICATIONS (2018)
Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer
Lingjian Yang et al.
EBIOMEDICINE (2018)
Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators
Lei Wei et al.
EUROPEAN UROLOGY (2017)
Translating prognostic prostate cancer gene signatures into the clinic
Ananya Choudhury et al.
TRANSLATIONAL CANCER RESEARCH (2017)
Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parameters
M. Linch et al.
ANNALS OF ONCOLOGY (2017)
Identifying aggressive prostate cancer foci using a DNA methylation classifier
Kamilla Mundbjerg et al.
GENOME BIOLOGY (2017)
Integrative Analysis of DCE-MRI and Gene Expression Profiles in Construction of a Gene Classifier for Assessment of Hypoxia-Related Risk of Chemoradiotherapy Failure in Cervical Cancer
Christina S. Fjeldbo et al.
CLINICAL CANCER RESEARCH (2016)
A new contemporary prostate cancer grading system
Jonathan I. Epstein
ANNALES DE PATHOLOGIE (2015)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
Gene Expression Signatures as Biomarkers of Tumour Hypoxia
B. H. L. Harris et al.
CLINICAL ONCOLOGY (2015)
Spatial genomic heterogeneity within localized, multifocal prostate cancer
Paul C. Boutros et al.
NATURE GENETICS (2015)
Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue
Colin S. Cooper et al.
NATURE GENETICS (2015)
Genomic, pathological, and clinical heterogeneity as drivers of personalized medicine in prostate cancer
Michael Fraser et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study
H. Ross-Adams et al.
EBIOMEDICINE (2015)
The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer
H. B. Ragnum et al.
BRITISH JOURNAL OF CANCER (2015)
The challenge of intratumour heterogeneity in precision medicine
J. Seoane et al.
JOURNAL OF INTERNAL MEDICINE (2014)
Targeted prostate biopsies for a histogram of the index lesion
Osamu Ukimura et al.
CURRENT OPINION IN UROLOGY (2013)
Exome Sequencing of Prostate Cancer Supports the Hypothesis of Independent Tumour Origins
Johan Lindberg et al.
EUROPEAN UROLOGY (2013)
Tumor Hypoxia Predicts Biochemical Failure following Radiotherapy for Clinically Localized Prostate Cancer
Michael Milosevic et al.
CLINICAL CANCER RESEARCH (2012)
Hypoxic Prostate/Muscle PO2 Ratio Predicts for Outcome in Patients With Localized Prostate Cancer: Long-Term Results
Aruna Turaka et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Robot-assisted laparoscopic prostatectomy in a 68-year-old patient with previous heart transplantation and pelvic irradiation
Karol Axcrona et al.
JOURNAL OF ROBOTIC SURGERY (2012)
International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume
Theo H. van der Kwast et al.
MODERN PATHOLOGY (2011)
Multifocal prostate cancer: biologic, prognostic, and therapeutic implications
Matei Andreoiu et al.
HUMAN PATHOLOGY (2010)
Heterogeneity and Power in Clinical Biomarker Studies
Melania Pintilie et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Hypoxia in prostate cancer: Correlation of bold-MRI with pimonidazole immunohistochemistry - Initial observations
Peter J. Hoskin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: Implications for radioresistance
Dawn M. Carnell et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy
SJ Freedland et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer
C Parker et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: Long-term results
KA Roehl et al.
JOURNAL OF UROLOGY (2004)
Share Paper
